Molecular Cancer Therapeutics  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeBonis, S.
Right arrow Articles by Kozielski, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeBonis, S.
Right arrow Articles by Kozielski, F.
Mol Cancer Ther. 2004;3:1079-1090
© 2004 American Association for Cancer Research

In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities

Salvatore DeBonis1, Dimitrios A. Skoufias1, Luc Lebeau2, Roman Lopez3, Gautier Robin1, Robert L. Margolis1, Richard H. Wade1 and Frank Kozielski1

1 Institut de Biologie Structurale, Grenoble, France; 2 Laboratoire de Chimie Organique Appliquée, Centre National de la Recherche Scientifique, Université Louis Pasteur, Faculté de Pharmacie, Illkirch, France; and 3 Service de Marquage Moléculaire et de Chimie Bio-organique, CEA-Saclay, Gif sur Yvette, France

Requests for reprints: Frank Kozielski, Institut de Biologie Structurale, 41, rue Jules Horowitz, 38027 Grenoble Cedex 01, France. Phone: 33-4-3878-4024; Fax: 33-4-3878-5494. E-mail: Frank.Kozielski{at}ibs.fr

Human Eg5, a member of the kinesin superfamily, plays a key role in mitosis, as it is required for the formation of a bipolar spindle. We describe here the first in vitro microtubule-activated ATPase-based assay for the identification of small-molecule inhibitors of Eg5. We screened preselected libraries obtained from the National Cancer Institute and identified S-trityl-L-cysteine as the most effective Eg5 inhibitor with an IC50 of 1.0 µmol/L for the inhibition of basal ATPase activity and 140 nmol/L for the microtubule-activated ATPase activity. Subsequent cell-based assays revealed that S-trityl-L-cysteine induced mitotic arrest in HeLa cells (IC50, 700 nmol/L) with characteristic monoastral spindles. S-trityl-L-cysteine is 36 times more potent for inducing mitotic arrest than the well-studied inhibitor, monastrol. Gossypol, flexeril, and two phenothiazine analogues were also identified as Eg5 inhibitors, and we found that they all result in monoastral spindles in HeLa cells. It is notable that all the Eg5 inhibitors identified here have been shown previously to inhibit tumor cell line growth in the NCI 60 tumor cell line screen, and we conclude that their antitumor activity may at least in part be explained by their ability to inhibit Eg5 activity.


Grant support: Association pour la Recherche sur le Cancer contract no. 5197 (F. Kozielski), Alliance des Recherches sur le Cancer, Region Rhône-Alpes contract nos. 03 013690 02 and 03 013690 01, and Conseil Régional d'Ile de France (R. Lopez).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

4 http://dtp.nci.nih.gov/branches/dscb/diversity_explanation.html.

5 http://dtp.nci.nih.gov/branches/dscb/mechanistic_explanation.html.

6 http://dtp.nci.nih.gov/branches/btb/ivclsp.html.

Received 3/15/04; revised 6/ 8/04; accepted 7/ 6/04.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. C. Krzysiak, M. Grabe, and S. P. Gilbert
Getting in Sync with Dimeric Eg5: INITIATION AND REGULATION OF THE PROCESSIVE RUN
J. Biol. Chem., January 25, 2008; 283(4): 2078 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. M. Chin and R. Herbst
Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Mol. Cancer Ther., October 1, 2006; 5(10): 2580 - 2591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Skoufias, S. DeBonis, Y. Saoudi, L. Lebeau, I. Crevel, R. Cross, R. H. Wade, D. Hackney, and F. Kozielski
S-Trityl-L-cysteine Is a Reversible, Tight Binding Inhibitor of the Human Kinesin Eg5 That Specifically Blocks Mitotic Progression
J. Biol. Chem., June 30, 2006; 281(26): 17559 - 17569.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. A. Cameron, G. Yang, D. Cimini, J. C. Canman, O. Kisurina-Evgenieva, A. Khodjakov, G. Danuser, and E.D. Salmon
Kinesin 5-independent poleward flux of kinetochore microtubules in PtK1 cells
J. Cell Biol., April 24, 2006; 173(2): 173 - 179.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Xiao, J. T. Pinto, G. G. Gundersen, and I. B. Weinstein
Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells
Mol. Cancer Ther., September 1, 2005; 4(9): 1388 - 1398.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.